A detailed history of Inverness Counsel LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Inverness Counsel LLC holds 252,178 shares of JNJ stock, worth $36.8 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares
252,178
Previous 259,471 2.81%
Holding current value
$36.8 Million
Previous $46.1 Million 10.56%
% of portfolio
2.29%
Previous 2.58%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

SELL
$161.33 - $179.52 $1.18 Million - $1.31 Million
-7,293 Reduced 2.81%
252,178 $41.2 Million
Q2 2022

Jul 20, 2022

BUY
$168.19 - $186.01 $621,798 - $687,678
3,697 Added 1.45%
259,471 $46.1 Million
Q1 2022

May 05, 2022

BUY
$158.14 - $179.59 $25.6 Million - $29.1 Million
161,813 Added 172.21%
255,774 $45.3 Million
Q4 2021

Feb 07, 2022

SELL
$155.93 - $173.01 $3.75 Million - $4.16 Million
-24,062 Reduced 20.39%
93,961 $16.1 Million
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $9.94 Million - $11 Million
61,561 Added 109.03%
118,023 $19.1 Million
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $4.52 Million - $4.85 Million
-28,323 Reduced 33.41%
56,462 $9.3 Million
Q1 2021

May 04, 2021

SELL
$153.07 - $170.48 $33 Million - $36.8 Million
-215,703 Reduced 71.78%
84,785 $13.9 Million
Q4 2020

Jan 27, 2021

SELL
$137.11 - $157.38 $2.2 Million - $2.53 Million
-16,073 Reduced 5.08%
300,488 $47.3 Million
Q3 2020

Nov 03, 2020

BUY
$140.38 - $153.83 $450,619 - $493,794
3,210 Added 1.02%
316,561 $47.1 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $623,569 - $752,823
4,841 Added 1.57%
313,351 $44.1 Million
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $3.5 Million - $4.85 Million
-31,521 Reduced 9.27%
308,510 $40.5 Million
Q4 2019

Feb 05, 2020

BUY
$127.5 - $146.44 $14.3 Million - $16.5 Million
112,379 Added 49.36%
340,031 $49.6 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $5.53 Million - $6.19 Million
43,569 Added 23.67%
227,652 $29.5 Million
Q2 2019

Aug 07, 2019

BUY
$131.15 - $144.24 $15 Million - $16.5 Million
114,505 Added 164.57%
184,083 $25.6 Million
Q1 2019

May 09, 2019

SELL
$125.72 - $139.79 $190,465 - $211,781
-1,515 Reduced 2.13%
69,578 $9.73 Million
Q4 2018

Jan 29, 2019

BUY
$122.84 - $147.84 $2.59 Million - $3.12 Million
21,116 Added 42.25%
71,093 $9.17 Million
Q3 2018

Oct 30, 2018

BUY
$121.58 - $142.88 $128,145 - $150,595
1,054 Added 2.15%
49,977 $6.91 Million
Q2 2018

Aug 02, 2018

SELL
$119.4 - $131.76 $5.97 Million - $6.58 Million
-49,966 Reduced 50.53%
48,923 $5.94 Million
Q1 2018

May 02, 2018

SELL
$125.1 - $148.14 $1.53 Million - $1.81 Million
-12,203 Reduced 10.98%
98,889 $12.7 Million
Q4 2017

Feb 02, 2018

BUY
$131.22 - $143.62 $8.64 Million - $9.46 Million
65,843 Added 145.51%
111,092 $15.5 Million
Q3 2017

Oct 17, 2017

BUY
$129.47 - $135.38 $5.86 Million - $6.13 Million
45,249
45,249 $5.88 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Inverness Counsel LLC Portfolio

Follow Inverness Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.